DUBLIN--(BUSINESS WIRE)--The "Artificial Intelligence-based Clinical Trial Solutions for Patient Matching - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering ...

San Francisco-based Mendel.ai, a startup that is developing an artificial intelligence-powered platform to match people with cancer to clinical trials, has raised $2 million in seed funding from DCM ...

NEW YORK--(BUSINESS WIRE)--Massive Bio, a cutting-edge AI driven clinical trial matching platform provider, and Foundation Medicine, Inc. today announced a strategic collaboration to increase patient ...

A comprehensive search was conducted in PubMed, Web of Science, and OpenAlex for literature published between December 1, 2022, and December 31, 2024. Studies were included if they explicitly ...

We created a hybrid rules–based and natural language processing (NLP)–based pipeline that automatically screens patients using structured and unstructured electronic health record data standardized to ...

Researchers from the National Institutes of Health (NIH) have developed an artificial intelligence (AI) algorithm to help speed up the process of matching potential volunteers to relevant clinical ...

Researchers from the National Institutes of Health are using large language models to develop an artificial intelligence framework to streamline the clinical trial matching process and more quickly ...

Add Yahoo as a preferred source to see more of our stories on Google. For cancer patients, medicines administered in clinical trials can help save or extend lives. But despite thousands of trials in ...

STUDIO CITY, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) is excited to announce that it has partnered with SparkCures to bring an innovative solution to ...

What is the work that you’re leading in harnessing real world evidence to develop novel therapies? Over the past few years, we’ve worked collaboratively with hospitals, research centers and life ...